(2)
Now Has 78 Patents Issued, Filed, Licensed or in Preparation As Taeus Commercial Launch Plans Advance
ANN ARBOR, MI / ACCESSWIRE / December 15, 2020 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS
®), has recently been issued Chinese Patent ZL 2016 8 00267062 (the 062 patent) entitled Systems and Methods for Imaging Biological Tissue Structures from the Chinese Intellectual Property Office (SIPO). This is the seventh Chinese patent issued to ENDRA for its TAEUS technology. ENDRA s goal is to develop applications for our proprietary TAEUS technology in areas of high unmet clinical need and for which there are no practical existing tools. The recently issued 062 patent provides more robust intellectual property (IP) protection for our TAEUS platform in a key global market where an estimated 30% of its 1.4 billion citizens are affected by Non-Alcoholic Fatty Liver Disease, said Francois Michelon, ENDRA s chief exec